Innovative cancer biomarker technologies
Imagine if doctors could practise under the most realistic conditions as part of training and before they undertook significant surgery – that’s the aim of OrganLike. The company wants to make surgery more safe and effective by ensuring medical professionals, both in their training and beyond, are best prepared for the rigours of this most technically demanding of roles.
With a mission to support safer and more effective surgery. OrganLike aspire to be the global leader producing “hyper-real” organ models and tools for use in surgical simulation, medical training and for the medical device industry.
The company’s breakthrough hydro-gel body-part models – so lifelike they have to be seen to be believed – are used to train surgeons for complex procedures.
The company’s breakthrough hydro-gel body-part models – so lifelike they have to be seen to be believed – are used to train surgeons for complex procedures, providing the closest live environment to the real-life situations they’ll face. Using water-based materials curbs demand for traditional organic materials and therefore reduces the need for costly disinfection protocols in both transit and usage.
The company's “hyper-real” products are equally useful to the medical supplies industry where they are deployed for demonstrating equipment, both in person and increasingly online and in visual simulations. The technology is also poised to be used to make models for specific medical instances where a degree of practice training would ensure the best possible outcome for the individual patient and medical team.
OrganLike has already notched up a number of significant sales including to medical device companies such as Boston Scientific, Olympus, Dexcom and Vascutek. It has also agreed a partnership with the Royal College of Surgeons in Edinburgh, which counts about 25,000 members globally.
Vivolution's engagement with OrganLike has shown the potential of partnership in a company’s journey to success, where we have worked with both Highlands and Islands Enterprise and Strathclyde University to build the company’s ecosystem.
With Vivolution's existing insights in the medical technology field, augmented by experience across the broad spectrum of industry, we recognised the choice OrganLike faced: search for high-value, low-volume business in the early years and remain research-project bound and limited in scope; or focus on volume and sales early on to drive momentum to allow the company reach its specialist targets more quickly and easily. After opting for the latter, Vivolution introduced the company to the top tier of medical providers and institutions, allowing for speedier market penetration and validation, which has opened up the prospects for OrganLike to be a truly global success story.
OrganLike have been support through Innovate UK and are rolling their product out to a wide community of surgeons, health institutions and global medical device companies. The Company have also produced complex models from individual MRI/CT scans, that have been successfully used to rehearse for life critical surgery. They are continuing to develop their 3D printing techniques, with a longer-term vision to bring organic 3D printers and inks to widespread use for health providers.